Literature DB >> 27169701

Exceptional patients and communication in cancer care-are we missing another survival factor?

Moshe Frenkel1,2, Joan C Engebretson3, Sky Gross4, Noemi E Peterson3, Ariela Popper Giveon5, Kenneth Sapire6, Doron Hermoni7.   

Abstract

OBJECTIVE: There is increased awareness of the issue of exceptional survival beyond expectations among cancer patients with poor prognosis, and researchers are starting to look closely at this phenomenon. In this study, we explored the perceptions of these "exceptional patients" as to their understanding and insight into their unusual experience.
METHODS: We used a qualitative approach consisting of in-depth, open-ended interviews with exceptional patients in two locations, Texas and Israel, from 2007 to 2014. The interviews were audio-recorded and qualitatively analyzed, and gave rise to illness narratives entailing detailed descriptions of patients experience over the course of their disease and treatment. A qualitative content analysis focusing on contextual meaning was utilized.
RESULTS: Twenty-nine patients participated in our study. The mean years since diagnosis was 9.55 years (range, 4-23 years). All patients had received conventional treatment, including surgery, chemotherapy, and radiation therapy. One of the prevailing themes in these interviews was related to the patient-doctor relationship. Most participants mentioned that the support they received from one or more physicians was a crucial factor for their exceptional survival.
CONCLUSION: The significance of patient-doctor relationship in cancer survival requires further research. This research is especially important as it adds to the current trend of patient centered care and points to the added value of relationship between health providers and patients. This relationship, as perceived by these exceptional patients, can be a factor that adds to improved survival in cancer care.

Entities:  

Keywords:  Cancer care; Cancer prognosis; Cancer survival; Exceptional patient; Exceptional physician; Patient-doctor communication; Remarkable recovery

Mesh:

Year:  2016        PMID: 27169701     DOI: 10.1007/s00520-016-3255-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  33 in total

1.  Patient perceptions of helpful communication in the context of advanced cancer.

Authors:  Kelli I Stajduhar; Sally E Thorne; Liza McGuinness; Charmaine Kim-Sing
Journal:  J Clin Nurs       Date:  2010-07       Impact factor: 3.036

Review 2.  The spontaneous regression of cancer. A review of cases from 1900 to 1987.

Authors:  G B Challis; H J Stam
Journal:  Acta Oncol       Date:  1990       Impact factor: 4.089

3.  Spontaneous regression of cancer.

Authors:  T C Everson
Journal:  Ann N Y Acad Sci       Date:  1964-04-02       Impact factor: 5.691

4.  Patient-health care provider communication during chemotherapy treatment: the perspectives of women with breast cancer.

Authors:  D A Bakker; M I Fitch; R Gray; E Reed; J Bennett
Journal:  Patient Educ Couns       Date:  2001-04

5.  Living outliers: experiences, insights and narratives of exceptional survivors of incurable cancer.

Authors:  Moshe Frenkel; Sky Gross; Ariela Popper Giveon; Kenneth Sapire; Doron Hermoni
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

6.  Exceptional patients: narratives of connections.

Authors:  Joan C Engebretson; Noemi E Peterson; Moshe Frenkel
Journal:  Palliat Support Care       Date:  2013-07-04

7.  Spontaneous remission of metastases of cancer of the uterine cervix.

Authors:  Anke B Gaussmann; Detlef Imhoff; Eveline Lambrecht; Christoph Menzel; Stefan Mose
Journal:  Onkologie       Date:  2006-03-29

8.  Spontaneous " healing" of breast cancer.

Authors:  Rie Horii; Futoshi Akiyama; Fujio Kasumi; Morio Koike; Goi Sakamoto
Journal:  Breast Cancer       Date:  2005       Impact factor: 4.239

9.  The relationship between social ties and survival among black and white breast cancer patients. National Cancer Institute Black/White Cancer Survival Study Group.

Authors:  P Reynolds; P T Boyd; R S Blacklow; J S Jackson; R S Greenberg; D F Austin; V W Chen; B K Edwards
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Apr-May       Impact factor: 4.254

Review 10.  Remarkable recoveries: research and practice from a patient's perspective.

Authors:  Marc Ian Barasch
Journal:  Hematol Oncol Clin North Am       Date:  2008-08       Impact factor: 3.722

View more
  5 in total

1.  A Qualitative Analysis of the Preoperative Needs of Patients With Papillary Thyroid Cancer.

Authors:  Susan C Pitt; Elizabeth Wendt; Megan C Saucke; Corrine I Voils; Jason Orne; Cameron L Macdonald; Nadine P Connor; Rebecca S Sippel
Journal:  J Surg Res       Date:  2019-07-12       Impact factor: 2.192

2.  Exceptional Survival Among Kentucky Stage IV Non-small Cell Lung Cancer Patients: Appalachian Versus Non-Appalachian Populations.

Authors:  Vira Pravosud; Nathan L Vanderford; Bin Huang; Thomas C Tucker; Susanne M Arnold
Journal:  J Rural Health       Date:  2020-11-18       Impact factor: 5.667

3.  Physician Empathy Interacts with Breaking Bad News in Predicting Lung Cancer and Pleural Mesothelioma Patient Survival: Timing May Be Crucial.

Authors:  Sophie Lelorain; Alexis Cortot; Véronique Christophe; Claire Pinçon; Yori Gidron
Journal:  J Clin Med       Date:  2018-10-17       Impact factor: 4.241

4.  Effects of continuity of care on the postradiotherapy survival of working-age patients with oral cavity cancer: A nationwide population-based cohort study in Taiwan.

Authors:  Tsu Jen Kuo; Pei Chen Wu; Pei Ling Tang; Chun-Hao Yin; Chi Hsiang Chu; Yao-Min Hung
Journal:  PLoS One       Date:  2019-12-16       Impact factor: 3.240

5.  Improving communication between the general practitioner and the oncologist: a key role in coordinating care for patients suffering from cancer.

Authors:  Vladimir Druel; Laetitia Gimenez; Kim Paricaud; Jean-Pierre Delord; Pascale Grosclaude; Nathalie Boussier; Marie-Eve Rougé Bugat
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.